{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/58468-0426#drug","name":"Nexviazyme","alternateName":"avalglucosidase alfa-ngpt","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"58468-0426"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761194"},{"@type":"PropertyValue","propertyID":"UNII","value":"EO144CP0X9"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"80eb3c9c-01d3-44fe-90ef-81df101b954d"}],"activeIngredient":"AVALGLUCOSIDASE ALFA","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Genzyme Corporation"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761194","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80eb3c9c-01d3-44fe-90ef-81df101b954d","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-0426"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T09:35:06.915Z"}}